Poehling Capital Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-21,503
| Closed | -$1.62M | – | 143 |
|
|
2025
Q3 | $1.62M | Sell |
21,503
-545
| -2% | -$37.4K | 0.34% | 64 |
|
|
2025
Q2 | $1.52M | Sell |
22,048
-16,453
| -43% | -$1.08M | 0.36% | 60 |
|
|
2025
Q1 | $2.61M | Sell |
38,501
-2,234
| -5% | -$134K | 0.66% | 50 |
|
|
2024
Q4 | $1.83M | Sell |
40,735
-1,202
| -3% | -$67.4K | 0.45% | 58 |
|
|
2024
Q3 | $2.64M | Sell |
41,937
-41,553
| -50% | -$2.42M | 0.67% | 49 |
|
|
2024
Q2 | $4.93M | Sell |
83,490
-2,730
| -3% | -$171K | 1.35% | 22 |
|
|
2024
Q1 | $6.88M | Sell |
86,220
-144
| -0.2% | -$11K | 1.84% | 15 |
|
|
2023
Q4 | $6.82M | Sell |
86,364
-89
| -0.1% | -$6.33K | 2.16% | 10 |
|
|
2023
Q3 | $6.04M | Sell |
86,453
-311
| -0.4% | -$22K | 2.11% | 13 |
|
|
2023
Q2 | $6M | Buy |
86,764
+182
| +0.2% | +$12.9K | 2.03% | 15 |
|
|
2023
Q1 | $6.43M | Buy |
86,582
+4,714
| +6% | +$395K | 2.17% | 11 |
|
|
2022
Q4 | $7.63M | Buy |
81,868
+3,021
| +4% | +$292K | 2.86% | 6 |
|
|
2022
Q3 | $7.52M | Sell |
78,847
-1,619
| -2% | -$160K | 3.15% | 5 |
|
|
2022
Q2 | $7.46M | Buy |
80,466
+706
| +0.9% | +$68.9K | 2.8% | 7 |
|
|
2022
Q1 | $8.07M | Sell |
79,760
-313
| -0.4% | -$32.9K | 2.49% | 8 |
|
|
2021
Q4 | $8.26M | Sell |
80,073
-157
| -0.2% | -$14.5K | 2.67% | 9 |
|
|
2021
Q3 | $6.81M | Buy |
80,230
+9
| +0% | +$754 | 2.3% | 11 |
|
|
2021
Q2 | $6.69M | Buy |
80,221
+1,748
| +2% | +$143K | 2.13% | 9 |
|
|
2021
Q1 | $5.9M | Buy |
78,473
+8,074
| +11% | +$588K | 2.07% | 8 |
|
|
2020
Q4 | $4.81M | Buy |
70,399
+353
| +0.5% | +$23K | 1.91% | 13 |
|
|
2020
Q3 | $4.09M | Sell |
70,046
-1,256
| -2% | -$78.2K | 2.1% | 10 |
|
|
2020
Q2 | $4.63M | Sell |
71,302
-740
| -1% | -$46.6K | 2.49% | 7 |
|
|
2020
Q1 | $4.27M | Sell |
72,042
-2,120
| -3% | -$142K | 3.13% | 6 |
|
|
2019
Q4 | $5.51M | Sell |
74,162
-75
| -0.1% | -$5.27K | 3.61% | 6 |
|
|
2019
Q3 | $4.68M | Sell |
74,237
-3,526
| -5% | -$209K | 3.44% | 5 |
|
|
2019
Q2 | $4.24M | Buy |
77,763
+3,181
| +4% | +$171K | 2.84% | 6 |
|
|
2019
Q1 | $4.02M | Buy |
74,582
+40,638
| +120% | +$2.51M | 2.93% | 6 |
|
|
2018
Q4 | $2.22M | Sell |
33,944
-502
| -1% | -$37.5K | 2.14% | 12 |
|
|
2018
Q3 | $2.71M | Buy |
34,446
+7,380
| +27% | +$528K | 1.92% | 12 |
|
|
2018
Q2 | $1.74M | Sell |
27,066
-7,175
| -21% | -$473K | 1.52% | 20 |
|
|
2018
Q1 | $2.13M | Buy |
34,241
+26,145
| +323% | +$1.88M | 1.72% | 12 |
|
|
2017
Q4 | $587K | Buy |
+8,096
| New | +$589K | 0.5% | 60 |
|
Other funds holding CVS
Poehling Capital Management's CVS Position: Q4 2025 in Review
Poehling Capital Management sold out of CVS Health (CVS) in Q4 2025, closing a stake of 21,503 shares — an estimated $1.62M sold.
Poehling Capital Management first reported a position in CVS in Q4 2017 and held it in 32 quarters. The position peaked at $8.26M in Q4 2021. 1,946 funds tracked by Wall St. Rank hold CVS as of Q4 2025.
- Poehling Capital Management reported no remaining CVS Health position as of Q4 2025 after selling out during the quarter.
- Poehling Capital Management sold 21,503 CVS Health shares in Q4 2025, an estimated $1.62M.
- Poehling Capital Management first reported a position in CVS Health in Q4 2017 and held it in 32 quarters.
- Poehling Capital Management's CVS Health position peaked at $8.26M in Q4 2021.
- 1,946 funds tracked by Wall St. Rank held CVS Health as of Q4 2025.
Based on Poehling Capital Management's 13F filing for Q4 2025, filed 6 Feb 2026.